Equillium (EQ) EBITDA (2018 - 2026)

Equillium (EQ) has 9 years of EBITDA data on file, last reported at -$5.3 million in Q1 2026.

• EBITDA for Q1 2026 came in at -$5.3 million, up 39.06% year-over-year; the trailing twelve-month figure through Mar 2026 was -$19.4 million (down 41.94% YoY), and the FY2025 annual result was -$22.8 million, down 207.24% from the prior year.
• EBITDA fell to -$5.3 million in Q1 2026 per EQ's latest filing, from -$3.7 million in the prior quarter.
• Over five years, EBITDA peaked at $2.7 million in Q4 2022 and troughed at -$37.7 million in Q1 2022.
• A 5-year average of -$6.5 million and a median of -$3.7 million in 2023 frame the typical range for EBITDA.
• The sharpest annual moves came in 2022 and 2025: EBITDA jumped 124.84% in 2022, then slumped 2155.74% in 2025.
• A 5-year view of EBITDA shows it stood at $2.7 million in 2022, then sank by 200.15% to -$2.7 million in 2023, then tumbled by 88.35% to -$5.0 million in 2024, then grew by 26.51% to -$3.7 million in 2025, then slumped by 44.05% to -$5.3 million in 2026.
• Business Quant data shows EQ's EBITDA at -$5.3 million in Q1 2026, -$3.7 million in Q4 2025, and -$4.3 million in Q3 2025.